Leaked Commission research documents raise questions about whose interests are being prioritized

8 October 2013

Scientists, public health researchers and non-governmental organizations (NGOs) have reacted with grave concern in light of leaked copies of the European Commission’s proposed Health Research Program 2014-2015 (part of Horizon2020) circulating in Brussels, according to a joint statement of the public health associations of Europe (IEA, ISEE, EUPHA).

They have raised questions regarding the preparation of this draft, given its failure to address the major personal, social, environmental and occupational risk factors of disease in favour of narrow research parameters focusing on biotechnology and personalised medicine.

“This program turns its back to research designed to mitigate the public health impacts of the economic crisis and underestimates the significance of health systems. All in all, this proposal does very little to address the health problems that keep people living in Europe awake at night,” said Walter Ricciardi, president of the European Public Health Association (EUPHA).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Biotechnology